Live Breaking News & Updates on Evere Bsln Ch0011432447

Stay updated with breaking news from Evere bsln ch0011432447. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Basilea announces transition milestone for oncology asset BAL0891, triggering milestone payment of USD 4 million by SillaJen

Basel/Allschwil, Switzerland, December 19, 2022 Basilea Pharmaceutica Ltd. , a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial. | December 19, 2022 ....

Basel Stadt , Basel Allschwil , Nils Schr , Marc Engelhardt , Basilea Pharmaceutica International Ltd , Head Of Corporate Communications Investor Relations , Sillajen Inc , Swiss Exchange , Basilea Pharmaceutica Ltd , Chief Medical Officer , Pharmaceutica Ltd , Corporate Communications , Pharmaceutica International Ltd , Basilea Pharmaceutica Ag Stock Exchange , Press Release , Evere Bsln Ch0011432447 ,